Inflammation as the key interface of the medical and nutrition universes: a provocative examination of the future of clinical nutrition and medicine

Journal of Parenteral and Enteral Nutrition

Volumn 30, Issue 5, 2006, Pages 453-463

  Jensen, Gordon L ^a,b,c  

^a Vanderbilt Center for Human Nutrition   (United States)

^b VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

^c Valley VA GRECC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; DIET THERAPY; FORECASTING; HUMAN; INFLAMMATION; METHODOLOGY; NUTRITIONAL ASSESSMENT; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PROGNOSIS; TREATMENT OUTCOME;

FORECASTING; HUMANS; INFLAMMATION; NUTRITION ASSESSMENT; NUTRITION THERAPY; NUTRITIONAL STATUS; NUTRITIONAL SUPPORT; PROGNOSIS; TREATMENT OUTCOME;

EID: 39049180656     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607106030005453     Document Type: Conference Paper

References (156)

1. Gorman G, Park A. The fires within. Time Magazine. Feb 23, 2004. Vol 163, No 8.
2. Cuthbertson D. The physiology of convalescence after injury. Br Med Bull. 1945;3:96-102.
3. Beutler B, Greenwald D, Hulmes JD, et al. Identity of tumor necrosis factor and the macrophage-secreted factor cachectin. Nature. 1985;316:552-554.
4. Deans C, Wigmore SJ. Systemic inflammation, cachexia and prognosis in patients with cancer. Curr Opin Clin Nutr Metab Care. 2005;8:265-269.
5. Zoico E, Roubenoff R. The role of cytokines in regulating protein metabolism and muscle function. Nutr Rev. 2002;60:39-51.
6. Bistrian BR, Blackburn GL, Hallowell E, Heddle R. Protein status of general surgical patients. JAMA. 1974;230:858-860.
7. Rothschild MA, Oratz M, Schreiber SS. Serum albumin. Hepa-tology. 1988;8:385-401.
8. Doweiko JP, Nompleggi DJ. The role of albumin in human physiology, part III: albumin and disease states. JPEN J Par-enter Enteral Nutr. 1991;15:476-483.
9. Rall LC, Roubenoff R, Harris TB. Albumin as a marker of nutritional health and status. In: Rosenberg IH, ed. Nutritional Assessment of Elderly Populations. New York, NY: Raven Press; 1995:1-17.
10. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004;17:432-437.
11. Halmi KA, Struss AL, Owen WP, Stegink LD. Plasma and erythrocyte amino acid concentrations in anorexia nervosa. JPEN J Parenter Enteral Nutr. 1987;11:458-464.
12. Shetty PS, Jung RT, Watrasiewicz KE, James WPT. Rapid-turnover transport proteins: an index of subclinical protein-energy malnutrition. Lancet. 1979;2:230-232.
13. Forse RA, Shizgal HM. Serum albumin and nutritional status. JPEN J Parenter Enteral Nutr. 1980;4:450-454.
14. Sullivan DH, Sun S, Walls RC. Protein energy undernutrition among elderly hospitalized patients: a prospective study. JAMA. 1999;281:2013-2019.
15. Carpentier YA, Barthel J, Bruyns J. Plasma protein concentrations in nutritional assessment. Proc Nutr Soc. 1982;4:405-417.
16. Boles JM, Garre MA, Youinou PY, et al. Nutritional status in intensive care unit patients: evaluation in 84 unselected patients. Crit Care Med. 1983;11:87-90.
17. Goldberg DM, Brown D. Advances in the application of biochemical tests to diseases of the liver and biliary tract: their role in diagnosis, prognosis, and the elucidation of pathogenic mechanisms. Clin Biochem. 1987;20:127-148.
18. Ingenbleek Y, Young V. Transthyretin (prealbumin) in health and disease: nutritional implications. Annu Rev Nutr. 1994;14: 495-533.
19. Smith FR, Goodman DS. The effect of disease of the liver, thyroid, and kidneys on the transport of vitamin A in human plasma. J Clin Invest. 1971;50:2426-2436.
20. Lopez-Hellin J, Baena-Fustegueras JA, Schwartz-Riera S, Gar-cia-Arumi E. Usefulness of short-lived proteins as nutritional indicators in surgical patients. Clin Nutr. 2002;21:119-125.
21. Harvey KB, Moldwer LL, Bistrian BR, Blackburn GL. Biological measures for the formulation of a hospital prognostic index. Am J Clin Nutr. 1981;34:2013-2022.
22. Anderson CF, Moxness K, Meister J, Burritt MF. The sensitivity and specificity of nutrition-related variables in relationship to the duration of hospital stay and rate of complications. Mayo Clin Proc. 1984;59:477-483.
23. Agarwal N, Acevedo F, Leighton LS, Cayten CG, Pitchumoni CS. Predictive ability of various nutritional variables for mortality in elderly people. Am J Clin Nutr. 1988;48:1173-1178.
24. Herrmann FR, Safran C, Levkoff SE, Minaker KL. Serum albumin level on admission as a predictor of death, length of stay, and readmission. Arch Intern Med. 1992;152:125-130.
25. Patterson BM, Cornell CN, Carbone B, Levine B, Chapman D. Protein depletion and metabolic stress in elderly patients who have a fracture of the hip. J Bone Joint Surg. 1992;74:251-260.
26. Volkert D, Kruse W, Oster P, Schlierf G. Malnutrition in geriatric patients: diagnostic and prognostic significance of nutritional parameters. Ann Nutr Metab. 1992;36:97-112.
27. McClave SA, Mitoraj TE, Thielmeier KA, Greenberg RA. Differentiating subtypes (hypoalbuminemic vs marasmic) of protein-calorie malnutrition: incidence and clinical significance in a university hospital setting. JPEN J Parenter Enteral Nutr. 1992;16:337-342.
28. Cederholm T, Jagren C, Hellstrom K. Outcome of protein-energy malnutrition in elderly medical patients. Am J Med. 1995; 98:67-74.
29. Sullivan DH, Walls RC. The risk of life-threatening complications in a select population of geriatric patients: the impact of nutritional status. J Am Coll Nutr. 1995;14:29-36.
30. Burness R, Horne G, Purdie G. Albumin levels and mortality in patients with hip fractures. N Z Med J. 1996;109:56-57.
31. D'Erasmo E, Pisani D, Ragno A, Romagnoli S, Spagna G, Acca M. Serum albumin level at admission: mortality and clinical outcome in geriatric patients. Am J Med Sci. 1997;314:17-20.
32. Friedmann JM, Jensen GL, Smiciklas-Wright H, McCamish MA. Predicting early nonelective hospital readmission in nutritionally compromised older adults. Am J Clin Nutr. 1997;65: 1714-1720.
33. Marinella MA, Markert RJ. Admission serum albumin level and length of hospitalization in elderly patients. South Med J. 1998;91:851-854.
34. Incalzi RA, Capparella O, Gemma A, et al. Inadequate caloric intake: a risk factor for mortality of geriatric patients in the acute-care hospital. Age Ageing. 1998;27:303-310.
35. Henderson CT, Trumbore LS, Mobarhan S, Benya R, Miles TP. Prolonged tube feeding in long-term care: nutritional status and clinical outcomes. J Am Coll Nutr. 1992;11:309-325.
36. Rudman D, Feller AG, Nagrag HS, Jackson DL, Rudman IW, Mattson DE. Relation of serum albumin concentration to death rate in nursing home men. JPEN Parenter Enteral Nutr. 1987; 11:360-363.
37. Ferguson RP, O'Connor P, Crabtree B, Batchelor A, Mitchell J, Coppola D. Serum albumin and prealbumin as predictors of clinical outcomes of hospitalized elderly nursing home residents. J Am Geriatr Soc. 1993;41:545-549.
38. Klonoff-Cohen H, Barett-Connor EL, Edelstein SL. Albumin levels as a predictor of mortality in the healthy elderly. J Clin Epidemiol. 1992;45:207-212.
39. Corti M, Guralnik JM, Salive ME, Sorkin JD. Serum albumin level and physical disability as predictors of mortality in older persons. JAMA. 1994;227:1036-1042.
40. Sahyoun NR, Jacques PF, Dallal G, Russell RM. Use of albumin as a predictor of mortality in the community-dwelling and institutionalized elderly populations. J Clin Epidemiol. 1996;49: 981-988.
41. Reuben DB, Ix JH, Greendale GA, Sceman TE. The predictive value of combined hypoalbuminemia and hypocholesterolemia in high functioning community-dwelling older persons. J Am Geriatr Soc. 1999;47:402-406.
42. Salive ME, Coroni-Huntley J, Phillips CL, et al. Serum albumin in older persons: relationship with age and health status. J Clin Epidemiol. 1992;45:213-221.
43. Jensen GL, Kita K, Fish J, Heydt D, Frey C. Nutrition risk screening characteristics of rural older persons: relation to functional limitations and health care charges. Am J Clin Nutr. 1997;66:819-828.
44. Noel MA, Smith TK, Ettinger WH. Characteristics and outcomes of hospitalized older patients who develop hypocholesterolemia. J Am Geriatr Soc. 1991;39:455-461.
45. Rudman D, Feller AG. Protein-calorie undernutrition in the nursing home. J Am Geriatr Soc. 1989;37:173-183.
46. Ettinger WH, Harris T, Verdery RB, Tracy R, Kouba E. Evidence for inflammation as a cause of hypocholesterolemia in older people. J Am Geriatr Soc. 1995;43:264-266.
47. Goichot B, Schlienger JL, Grunenberger F, Pradignac A, Aby MA. Low cholesterol concentrations in free-living elderly subjects: relations with dietary intake and nutritional status. Am J Clin Nutr. 1995;62:547-553.
48. Pepys MB. C-reactive protein fifty years on. Lancet. 1981;1: 653-657.
49. Deodhar SD. C-reactive protein: the best laboratory indicator available for monitoring disease activity. Cleve Clin J Med. 1989;56:126-130.
50. Linscheid P, Seboek D, Schaer DJ, Zulewski H, Keller U, Mul-ler B. Expression and secretion of procalcitonin and calcitonin gene-related peptide by adherent monocytes and macrophage-activated adipocytes. Crit Care Med. 2004;32:1715-1721.
51. Mitaka C. Clinical laboratory differentiation of infectious versus noninfectious systemic inflammatory response syndrome. Clin Chim Acta. 2005;351:17-29.
52. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, et al. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care. 2004;19:152-157.
53. Christ-Crain M, Muller B. Procalcitonon in bacterial infections: hype, hope, more or less? Swiss Med Wkly. 2005;135:451-460.
54. Stanley KE. Prognostic factors for survival in patients with inoperable lung cancer. J Natl Cancer Inst. 1980;65:25-32.
55. Dewys WD, Begg C, Lavin PT, et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients: Eastern Cooperative Oncology Group. Am J Med. 1980;69:491-497.
56. Buzby GP, Mullen JL, Matthews DC, Hobbs CL, Rosato EF. Prognostic nutritional index in gastrointestinal surgery. Am J Surg. 1980;139:160-167.
57. Ingenbleek Y, Carpentier YA. A prognostic inflammatory and nutritional index scoring critically ill patients. Int J Vitam Nutr Res. 1985;55:91-101.
58. Nelson KA, Walsh D. The cancer anorexia-cachexia syndrome: a survey of the prognostic inflammatory and nutritional index (PINI) in advanced disease. J Pain Symptom Manage. 2002;24: 424-428.
59. Roubenoff R, Heymsfield SB, Kehayias JJ, Cannon JG, Rosenberg IH. Standardization of nomenclature of body composition in weight loss. Am J Clin Nutr. 1997;66:192-196.
60. Roubenoff R. Inflammatory and hormonal mediators of cachexia. J Nutr. 1997;127(suppl 5):256S-259S.
61. Kushner I. Regulation of acute phase response by cytokines. . Perspect Biol Med. 1993;36:611-622.
62. Roubenoff R. The pathophysiology of wasting in the elderly. J Nutr. 1999;129(suppl 1S):256S-259S.
63. Abbasi AA, Rudman D. Observations on the prevalence of protein-calorie undernutrition in VA nursing homes. J Am Geriatr Soc. 1993;41:117-121.
64. Geerts SO, Legrand V, Charpentier J, Albert A, Rompen EH. Further evidence of the association between periodontal conditions and coronary artery disease. J Periodontal. 2004;75:1274-1280.
65. Meurman JH, Janket SJ, Qvarnstrom M, Nuutinen P. Dental infections and serum inflammatory markers in patients with and without severe heart disease. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2003;96:695-700.
66. Sullivan DH, Martin W, Flaxman NM, Hagen JE. Oral health problems and involuntary weight loss in a population of frail elderly. J Am Geriatr Soc. 1993;41:725-731.
67. Bailey RL, Ledikwe JH, Smiciklas-Wright H, Mitchell DC, Jensen GL. Persistent oral health problems associated with comorbidity and impaired diet quality in older adults. J Am Diet Assoc. 2004;104:1273-1276.
68. Jensen GL, Friedmann JM, Coleman CD, Smiciklas-Wright H. Screening for hospitalization and nutritional risks among community-dwelling older persons. Am J Clin Nutr. 2001;74:201-205.
69. Anker SD, Steinborn W, Strassburg S. Cardiac cachexia. Ann Med. 2004;36:518-529.
70. Mustafa I, Levere X. Metabolic and nutritional disorders in cardiac cachexia. Nutrition. 2001;17:756-760.
71. Cicoira M, Bolger AP, Doehner W, et al. High tumor necrosis factor alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine. 2001;15:80-86.
72. Ezzell L, Jensen GL. Malnutrition in chronic obstructive pulmonary disease. Am J Clin Nutr. 2000;72:1415-1416.
73. Schols A. Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease. Proc Nutr Soc. 2003;62:783-791.
74. Cano NJ, Pichard C, Roth H, et al; and the Clinical Research Group of the Societe Francophone de Nutrition Enterale et Parenterale. C-reactive protein and body mass index predict outcome in end-stage respiratory failure. Chest. 2004;12:540-546.
75. Blei AT. Infection, inflammation and hepatic encephalopathy, synergism redefined. J Hepatol. 2004;40:327-330.
76. Poeze M, Ramsay G, Buurman WA, Greve JW, Dentener M, Takala J. Increased hepatosplanchnic inflammation precedes the development of organ dysfunction after elective high-risk surgery. Shock. 2002;17:451-458.
77. Guarnieri G, Antonione R, Biolo G. Mechanisms of malnutrition in uremia. J Ren Nutr. 2003;13:153-157.
78. Stenvinkel P, Kettler M, Johnson RJ, et al. IL-10, IL-6, and TNF-alpha: central factors in the altered cytokine network of uremia: the good, the bad, and the ugly. Kidney Int. 2005;67: 1216-1233.
79. Stenvinkel P, Lindholm B, Heimburger O. Novel approaches in an integrated therapy of inflammatory-associated wasting in end-stage renal disease. Semin Dial. 2004;17:505-515.
80. Kalantar-Zadeh K, Kopple JD, Block G, Humphreys MH. A malnutrition-inflammation score is correlated with morbidity and mortality in maintenance hemodialysis patients. Am J Kidney Dis. 2001;38:1251-1263.
81. Honda H, Qureshi AR, Heimburger O, et al. Serum albumin, C-reactive protein, interleukin 6, and fetuin A as predictors of malnutrition, cardiovascular disease, and mortality in patients with ESRD. Am J Kidney Dis. 2006;47:139-148.
82. Utaka S, Avesani CM, Draibe SA, Kamimura MA, Andreoni S, Cuppari L. Inflammation is associated with increased energy expenditure in patients with chronic kidney disease. Am J Clin Nutr. 2005;82:801-805.
83. Bengmark S. Acute and chronic phase reaction: a mother of disease. Clin Nutr. 2004;23:1256-1266.
84. Maachi M, Pieroni L, Bruckert E, et al. Systemic low grade inflammation is related to both circulating and adipose tissue TNF alpha, leptin and IL-6 levels in obese women. Int J Obes Relat Metab Disord. 2004;28:993-997.
85. Alley DE, Seeman TE, Ki Kim J, Karlamangla A, Hu P, Crim-mins EM. Socioeconomic status and C-reactive protein levels in the US population: NHANES IV. Brain Behau Immunol. 2006. Epub ahead of print.
86. Aronson D, Bartha P, Zinder O, et al. Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord. 2004;28: 674-679.
87. Wisse BE. The inflammatory syndrome: the role of adipose tissue cytokines in metabolic disorders linked to obesity. J Am Soc Nephrol. 2004;15:2792-2800.
88. Esposito K, Giugliano D. The metabolic syndrome and inflammation: association or causation? Nutr Metab Cardiovasc Dis. 2004;14:228-232.
89. Lee YH, Pratley RE. The evolving role of inflammation in obesity and the metabolic syndrome. CurrDiab Rep. 2005;5:70-75.
90. Roubenoff R. Sarcopenic obesity: does muscle loss cause fat gain? Lessons from rheumatoid arthritis and osteoarthritis. Ann N Y Acad Sci. 2000;904:553-557.
91. Jensen GL. Obesity and functional decline: epidemiology and geriatric consequences. Clin Geriatr Med. 2005;21:677-687.
92. Hochberg MC, Lethbridge-Cejku M, Scott WW Jr, Reichle R, Plato CC, Tobin JD. The association of body weight, body fatness and body fat distribution with osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. J Rheum. 1995;22:488-493.
93. Jordan JM, Luta G, Renner JB, et al. Self-reported functional status in osteoarthritis of the knee in a rural southern community: the role of sociodemographic factors, obesity, and knee pain. Arthritis Care Res. 1996;9:272-278.
94. Walsmith J, Roubenoff R. Cachexia in rheumatoid arthritis. Int J Cardiol. 2002;85:89-99.
95. Walsmith J, Abad L, Kehayias J, Roubenoff R. Tumor necrosis factor-alpha production is associated with less body cell mass in women with rheumatoid arthritis. J Rheumatol. 2004;31:23-29.
96. Roubenoff R. Catabolism of aging: is it an inflammatory process? Curr Opin Clin Nutr Metab Care. 2003;6:295-299.
97. Payette H, Roubenoff R, Jacques PF, et al. Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study. J Am Geriatr Soc. 2003;51:1237-1243.
98. Reuben DB, Cheh Al, Harris TB, et al. Peripheral blood markers of inflammation predict mortality and functional decline in high-functioning community-dwelling older persons. J Am Geriatr Soc. 2002;50:638-644.
99. Reuben DB, Judd-Hamilton L, Harris TB, Seeman TE; MacArthur Studies of Successful Aging. The associations between physical activity and inflammatory markers in high-functioning older persons: MacArthur Studies of Successful Aging. J Am Geriatr Soc. 2003;51:1125-1130.
100. Kotler DP. Nutritional alterations associated with HIV infection. J Acquir Immune Defic Syndr. 2000;25(suppl):S81-S87.
101. Roubenoff R, Grinspoon S, Skolnik PR, et al. Roles of cytokines and testosterone in regulating lean body mass and resting energy expenditure in HIV-infected men. Am J Physiol Endocrinol Metab. 2002;283:E138-E145.
102. Todorov P, Cariuk P, McDevitt T, Coles B, Fearon K, Tisdale M. Characterization of a cachectic factor. Nature. 1996;379:739-742.
103. Lorite MJ, Cariuk P, Tisdale MJ. Induction of muscle degradation by a tumor factor. Br J Cancer. 1997;76:1035-1040.
104. Barber MD, Ross JA, Fearon KCH. Changes in nutritional, functional, and inflammatory markers in advanced pancreatic cancer. Nutr Cancer. 1999;35:106-110.
105. Falconer JS, Fearon KC, Ross JA, et al. Acute phase protein response and survival duration of patients with pancreatic cancer. Cancer. 1995;75:2077-2082.
106. McMillan DC, Canna K, McArdle CS. Systemic inflammatory response predicts survival following curative resection of colorectal cancer. Br J Surg. 2003;90:215-219. .
107. Raymond NC, Dysken M, Bettin K, et al. Cytokine production in patients with anorexia nervosa, bulimia nervosa, and obesity. Int J Eat Disord. 2000;28:293-302.
108. Kahl KG, Kruse N, Rieckmann P, Schmidt MH. Cytokine mRNA expression patterns in the disease course of female adolescents with anorexia nervosa. Psychneuroendocrinology. 2004;29:13-20.
109. Singer M, De Santis V, Vitale D, Jeffcoate W. Multiorgan failure is an adaptive, endocrine-mediated, metabolic response to overwhelming systemic inflammation. Lancet. 2004;364:545-548.
110. Paoloni-Giacobino A, Grimble R, Pichard C. Genomic interactions with disease and nutrition. Clin Nutr. 2003;22:507-514.
111. Minnich DJ, Moldawer LL. Anti-cytokine and anti-inflammatory therapies for the treatment of severe sepsis: progress and pitfalls. Proc Nutr Soc. 2004;63:437-441.
112. Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Dan-ner RL. Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med. 1994; 120:771-783.
113. Pinsky MR. Dysregulation of the immune response in severe sepsis. Am J Med Sci. 2004;328:220-229.
114. Sanborn WJ. New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease. Rev Gastroenterol Disord. 2005;5:10-18.
115. Holtmann MH, Neurath MF. Anti-TNF strategies in stenosing and fistulizing Crohn's disease. Int J Colorectal Dis. 2005;20: 1-8.
116. Brown MA. Antibody treatments of inflammatory arthritis. Curr Med Chem. 2005;12:2943-2946.
117. Reinhart K, Karzai W. Anti-tumor necrosis factor therapy in sepsis: update on clinical trials and lessons learned. Crit Care Med. 2001;29(suppl):S121-S125.
118. Van den Berghe G, Wouters PJ, Weekers F, et al. Intensive insulin therapy in critically ill patients. N Engl J Med. 2001; 345:1359-1367.
119. Hansen TK, Thiel S, Wouters PJ, Christiansen JS, Van den Berghe G. Intensive insulin therapy exerts anti-inflammatory effects in critically ill patients and counteracts the adverse effect of low mannose-binding lectin levels. J Clin Endocrinol Metab. 2003;88:1082-1088.
120. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354: 449-461.
121. Stump CS, Clark SE, Sowers JR. Oxidative stress in insulin-resistant conditions: cardiovascular implications. Treat Endocrinol. 2005;4:343-351.
122. Niedowicz DM, Daleke DL. The role of oxidative stress in diabetic complications. Cell Biochem Biophys. 2005;43:289-230.
123. Allen DA, Yaqoob MM, Harwood SM. Mechanisms of high glucose-induced apoptosis and its relationship to diabetic complications. J Nutr Biochem. 2005;16:705-713.
124. Langouche L, Vanhorebeek I, Vlasselaers D, et al. Intensive insulin therapy protects the endothelium of critically ill patients. J Clin Invest. 2005;115:2277-2286.
125. Moore F. Caution: use fat emulsions judiciously in intensive care patients. Crit Care Med. 2001;29:1644-1645.
126. Waitzberg DL, Lotierzo PH, Logullo AF, Torrinhas RS, Pereira CC, Meier R. Parenteral lipid emulsions and phagocytic systems. Br J Nutr. 2002;87(suppl):S49-S57.
127. Mayer K, Gokorsch S, Fegbeutel C, et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med. 2003;167:1321-1328.
128. Roller M, Senkal M, Kemen M, Konig W, Zumtobel V, Muhr G. Impact of omega-3 fatty acid enriched TPN on leukotriene synthesis by leukocytes after major surgery. Clin Nutr. 2003; 22:59-64.
129. Roy CC, Bouthillier L, Seidman E, Levy E. New lipids in enteral feeding. Curr Opin Clin Nutr Metab Care. 2004;7:117-122.
130. Grimble RF. Immunonutrition. Curr Opin Gastroenterol. 2005; 21:216-222.
131. Pattison DJ, Symmons DP, Young A. Does diet have a role in the etiology of rheumatoid arthritis? Proc Nutr Soc. 2004;63: 137-143.
132. MacLean CH, Mojica WA, Newberry SJ, et al. Systematic review of the effects of n-3 fatty acids in inflammatory bowel disease. Am J Clin Nutr. 2005;82:611-619.
133. Gadek JE, DeMichele SJ, Karlstad MD, et al. Effect of enteral feeding with eicosapentaenoic acid, gamma-linolenic acid, arid antioxidants in patients with acute respiratory distress syndrome: Enteral Nutrition in ARDS Study Group. Crit Care Med. 1999;27:1409-1420.
134. Singer P, Theilla M, Fisher H, Gibstein L, Grozovski E, Cohen J. Benefit of an enteral diet enriched with eicosapentaenoic acid and gamma-linolenic acid in ventilated patients with acute lung injury. Crit Care Med. 2006;34:1265-1267. Erratum: 2006; 34:1861.
135. Wu D, Han SN, Meydani M, Meydahi SN. Effect of concomitant consumption of fish oil arid vitamin E on production of inflammatory cytokines in healthy elderly humans. Ann N YAcad Sci. 2004;1031:422-424.
136. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr. 2005;135:562-566.
137. Fung TT, McCullough ML, Newby PK, et al. Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction. Am J Clin Nutr. 2005;82:163-173.
138. Sanderson IR, Croft NM. The anti-inflammatory effects of enteral nutrition. JPEN J Parenter Enteral Nutr. 2005; 29(suppl):S134-S138.
139. Kudsk KA. Effect of route and type of nutrition on intestine-derived inflammatory responses. Am J Surg. 2003;185:16-21.
140. Peterson VM; Moore EE, Jones TN, et al. Total enteral nutrition versus total parenteral nutrition after major torso injury: attenuation of hepatic reprioritization. Surgery. 1988; 104:199-207.
141. Wu Y, Kudsk KA, DeWitt RC, Tolley EA, Li J. Route and type of nutrition influence IgA-mediated intestinal cytokines. Ann Surg. 1999;229:662-668.
142. Bengmark S. Synbiotics arid the mucosal barrier in critically ill . patients. Curr Opin Gastroenterol. 2005;21:712-716.
143. Isolauri E, Salminen S. Probiotics, gut inflammation and barrier function. Gastroenterol Clin North Am. 2005;34:437-450.
144. Laaksonen DE, Lindstrom J, Lakka TA, et al; for the Finnish Diabetes Prevention Study. Physical activity in the prevention of type 2 diabetes: the Finnish Diabetes Prevention Study. Diabetes. 2005;54:158-165.
145. Stewart KJ, Bacher AC, Turner K, et al. Exercise and risk factors associated with rrietabolic syndrome in older adults. Am J Prev Med. 2005;28:9-18.
146. Kettunen JA, Kujala UM. Exercise therapy for people with rheumatoid arthritis and osteoarthritis. Scand J Med Sci Sports. 2004;14:138-142.
147. Castaneda C, Gordon PL, Parker RC, Uhlin KL, Roubenoff R, Levey AS. Resistance training to reduce the malnutrition-inflammation complex syndrome of chronic kidney disease. 2004; 43:607-616.
148. Nicklas BJ, Ambrosius W, Messier SP, et al. Diet-induced weight loss, exercise, and chronic inflammation in older, obese adults: a randomized controlled trial. Am J Clin Nutr. 2004;79: 544-551.
149. Jellema A, Plat J, Mensink RP. Weight reduction, but riot moderate intake of fish oil, lowers concentrations of inflammatory markers and PAI-1 in obese men during the fasting and postprandial state. Eur J Clin Invest. 2004;34:766-773.
150. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEBJ. 2004;18:1657-1669.
151. Vincent HK, Taylor AG. Biomarkers and potential mechanisms of obesity-induced oxidant stress in humans. Int J Obes. 2006; 30:400-418.
152. Lopes HF, Martin KL, Nashar K, Morrow JD, Goodfriend TL, .Egan BM. DASH diet lowers blood pressure and lipid-induced oxidative stress in obesity. Hypertension. 2003;41:422-430.
153. Bathum L, Bomemenn JV, Christiansen L, Madsen JS, Skytthe A, Christensen K. Evidence for an association of methylene tetrahydrofolate reductase polymorphism C677T and an increased risk of fractures: results from a population-based Danish twin study. Osteoporos Int. 2004;15:659-664.
154. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med. 1991;324:1149-1155.
155. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine as a risk factor for dementia and Alzheimer's disease. N Engl J Med. 2002;346:476-483.
156. McLean RR, Jaques PF, Selhub J, et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med. 2004;350:2042-2049.